Michaela Kniessel

Title: Michaela Kniessel: Innovator in Antibody Research

Introduction

Michaela Kniessel is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a focus on treating bone abnormalities, her work has the potential to impact many lives.

Latest Patents

Michaela Kniessel holds 2 patents related to her innovative research. Her latest patents include "Polynucleotides encoding antibodies against sclerostin and uses therefor." This invention pertains to antibodies against sclerostin and outlines compositions and methods for using these antibodies to treat pathological disorders mediated by sclerostin, including diseases related to bone abnormalities such as osteoporosis. Another patent, "Compositions and methods for use for antibodies against sclerostin," further explores the therapeutic applications of these antibodies in treating similar conditions.

Career Highlights

Kniessel is currently associated with Novartis AG, a leading global healthcare company. Her role at Novartis allows her to collaborate with other experts in the field and contribute to groundbreaking research in antibody development.

Collaborations

Some of her notable coworkers include Christine Halleux and Shou-Ih Hu. Their collaboration enhances the research environment and fosters innovation within their projects.

Conclusion

Michaela Kniessel's work in antibody research exemplifies the impact of innovative thinking in biotechnology. Her patents and collaborations position her as a key figure in the fight against bone-related diseases.